Market Research Logo

Pharmaceutical Drugs Global Market Report 2018 Including: Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous System Drugs; Genito-urinary Drugs; Respiratory Diseases Drug

Pharmaceutical Drugs Global Market Report 2018 Including: Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous System Drugs; Genito-urinary Drugs; Respiratory Diseases Drugs; Gastrointestinal Drugs; Hematology Drugs; Dermatology Drugs; Ophthalmology DrugsCovering: Novartis AG,Sanofi S.A,F. Hoffmann-La Roche Ltd,Pfizer Inc,Gilead Sciences Inc

Pharmaceutical Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs market.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.

Scope

Markets Covered: Musculoskeletal Disorders Drugs; Cardiovascular Drugs; Oncology Drugs; Anti-infective Drugs; Metabolic Disorders Drugs; Central Nervous System Drugs; Genito-urinary Drugs; Respiratory Diseases Drugs; Gastrointestinal Drugs; Hematology Drugs; Dermatology Drugs; Ophthalmology Drugs

Companies Mentioned: Novartis AG,Sanofi S.A,F. Hoffmann-La Roche Ltd,Pfizer Inc,Gilead Sciences Inc

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Pharmaceutical Drugs Market Characteristics
2. Pharmaceutical Drugs Market Size And Growth
2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth, Value ($ Billion)
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market;
3. Pharmaceutical Drugs Trends And Strategies;
4. Pestle Analysis
4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental;
5. Pharmaceutical Drugs Market Customer Information;
6. Pharmaceutical Drugs Market Regional And Country Analysis
6.1. Global Pharmaceutical Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
6.2. Global Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, By Region
6.3. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Region
6.4. Global Pharmaceutical Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
6.5. Global Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, By Country
6.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country
7. Pharmaceutical Drugs Market Segmentation
7.1. Global Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
7.2. Global Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
8. Pharmaceutical Drugs Market Segments
8.1.Musculoskeletal Disorders Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Musculoskeletal Disorders Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Musculoskeletal Disorders Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.2.Cardiovascular Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Cardiovascular Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Cardiovascular Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.3.Oncology Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Oncology Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Oncology Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.4.Anti-infective Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Anti-infective Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Anti-infective Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.5.Metabolic Disorders Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Metabolic Disorders Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Metabolic Disorders Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.6.Central Nervous System Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Central Nervous System Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.7.Genito-urinary Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Genito-urinary Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Genito-urinary Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.8.Respiratory Diseases Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Respiratory Diseases Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.9.Gastrointestinal Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Gastrointestinal Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.10.Hematology Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Hematology Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Hematology Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.11.Dermatology Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Dermatology Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Dermatology Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
8.12.Ophthalmology Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Ophthalmology Drugs Market, 2017, By Segment, Value ($ Billion)
d) Global Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, By Segment
9. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors
9.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
9.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
10. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
10.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
10.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
11. Pharmaceutical Drugs Market Comparison With Industry Metrics
11.1. Global Number Of Pharmacists, 2017, By Country
11.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2017, By Country
11.3. Global Number Of Pharma Enterprises, 2017, By Country
11.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
11.5. Global Number Of Employees In Pharmaceutical Industry, 2017, By Country
11.1.6 Global Pharmaceuticals Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2017, By Country
11.1.7 Global Average Spending On R&D/Product Development, 2017, By Country
11.1.8 Global Pharmaceuticals Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
11.1.9 Global Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2017, By Country
11.1.10 Global Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2017, By Country
11.1.11 Global Number Of Pharmacies, 2017, By Country
11.1.12 Global Pharmaceuticals Market Revenue Versus Number Of Pharmacies, 2017, By Country
11.1.13 Global New Drug Approvals, 2017, By Country
11.1.14 Global Pharmaceuticals Market Revenue Versus New Drug Approvals, 2017, By Country
11.1.15 Global Number Of General Practitioners 2017, By Country
11.1.16 Global Pharmaceuticals Market Revenue Versus Number Of General Practitioners, 2017, By Country
12. Asia-Pacific Pharmaceutical Drugs Market
12.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview
12.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
12.1.5. Asia-Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis
12.3. China Pharmaceutical Drugs Market
12.3.1. China Pharmaceutical Drugs Market Overview
12.3.2. China Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.3.3. China Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.3.4. China Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
12.3.5. China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.4. India Pharmaceutical Drugs Market
12.4.1. India Pharmaceutical Drugs Market Overview
12.4.2. India Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.4.3. India Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.4.4. India Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
12.4.5. India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.5. Japan Pharmaceutical Drugs Market
12.5.1. Japan Pharmaceutical Drugs Market Overview
12.5.2. Japan Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.5.3. Japan Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.5.4. Japan Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
12.5.5. Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.5.6. Japan Pharmaceutical Drugs Market Comparison With Industry Metrics
12.5.6.1 Japan Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
12.5.6.2 Japan Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
12.6. Australia Pharmaceutical Drugs Market
12.6.1. Australia Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.6.2. Australia Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.6.3. Australia Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
12.6.4. Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13. Western Europe Pharmaceutical Drugs Market
13.1.1. Western Europe Pharmaceutical Drugs Market Overview
13.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.1.4. Western Europe Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
13.1.5. Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.2. Western Europe Pharmaceutical Drugs Market: Country Analysis
13.3. UK Pharmaceutical Drugs Market
13.3.1. UK Pharmaceutical Drugs Market Overview
13.3.2. UK Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.3.3. UK Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.3.4. UK Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
13.3.5. UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.3.6. UK Pharmaceutical Drugs Market Comparison With Industry Metrics
13.3.6.1 UK Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.3.6.2 UK Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.4. Germany Pharmaceutical Drugs Market
13.4.1. Germany Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.4.2. Germany Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.4.3. Germany Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
13.4.4. Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.4.5. Germany Pharmaceutical Drugs Market Comparison With Industry Metrics
13.4.5.1 Germany Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.4.5.1 Germany Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.5 France Pharmaceutical Drugs Market
13.5.1 France Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.5.2 France Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.5.3. France Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
13.5.4. France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.5.5. France Pharmaceutical Drugs Market Comparison With Industry Metrics
13.5.5.1 France Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.5.5.2 France Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.6. Italy Pharmaceutical Drugs Market
13.6.1. Italy Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.6.2. Italy Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.6.3. Italy Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
13.6.4. Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.6.5. Italy Pharmaceutical Drugs Market Comparison With Industry Metrics
13.6.5.1 Italy Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.6.5.2 Italy Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.7. Spain Pharmaceutical Drugs Market
13.7.1. Spain Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.7.2. Spain Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.7.3. Spain Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
13.7.4. Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.7.5. Spain Pharmaceutical Drugs Market Comparison With Industry Metrics
13.7.5.1 Spain Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
13.7.5.2 Spain Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
14. Eastern Europe Pharmaceutical Drugs Market
14.1.1. Eastern Europe Pharmaceutical Drugs Market Overview
14.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
14.1.4. Eastern Europe Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
14.1.5. Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
14.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis
14.3. Russia Pharmaceutical Drugs Market
14.3.1. Russia Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.3.2. Russia Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
14.3.3. Russia Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
14.3.4. Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15. North America Pharmaceutical Drugs Market
15.1.1. North America Pharmaceutical Drugs Market Overview
15.1.2. North America Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.1.3. North America Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
15.1.4. North America Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
15.1.5. North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15.2. North America Pharmaceutical Drugs Market: Country Analysis
15.3. USA Pharmaceutical Drugs Market
15.3.1. USA Pharmaceutical Drugs Market Overview
15.3.2. USA Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.3.3. USA Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
15.3.4. USA Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
15.3.5. USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15.3.6. USA Pharmaceutical Drugs Market Comparison With Industry Metrics
15.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
15.3.6.2 USA Pharmaceuticals Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume (Million Units)), 2013 - 2017
16. South America Pharmaceutical Drugs Market
16.1.1. South America Pharmaceutical Drugs Market Overview
16.1.2. South America Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.1.3. South America Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
16.1.4. South America Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
16.1.5. South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
16.2. South America Pharmaceutical Drugs Market: Country Analysis
16.3. Brazil Pharmaceutical Drugs Market
16.3.1. Brazil Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
16.3.3. Brazil Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
16.3.4. Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
17. Middle East Pharmaceutical Drugs Market
17.1.1. Middle East Pharmaceutical Drugs Market Overview
17.1.2. Middle East Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
17.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
17.1.4. Middle East Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
17.1.5. Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
18. Africa Pharmaceutical Drugs Market
18.1.1. Africa Pharmaceutical Drugs Market Overview
18.1.2. Africa Pharmaceutical Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
18.1.3. Africa Pharmaceutical Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
18.1.4. Africa Pharmaceutical Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Musculoskeletal Disorders Drugs
Cardiovascular Drugs
Oncology Drugs
Anti-infective Drugs
Metabolic Disorders Drugs
Central Nervous System Drugs
Genito-urinary Drugs
Respiratory Diseases Drugs
Gastrointestinal Drugs
Hematology Drugs
Dermatology Drugs
Ophthalmology Drugs
18.1.5. Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
19. Pharmaceutical Drugs Market Competitive Landscape
19.1. Company Profiles
19.2. Novartis AG
19.2.1. Overview
19.2.2. Products And Services
19.2.3. Strategy
19.2.4. Financial Performance
19.3. Sanofi S.A
19.3.1. Overview
19.3.2. Products And Services
19.3.3. Strategy
19.3.4. Financial Performance
19.4. F. Hoffmann-La Roche Ltd
19.4.1. Overview
19.4.2. Products And Services
19.4.3. Strategy
19.4.4. Financial Performance
19.5. Pfizer Inc
19.5.1. Overview
19.5.2. Products And Services
19.5.3. Strategy
19.5.4. Financial Performance
19.6. Gilead Sciences, Inc
19.6.1. Overview
19.6.2. Products And Services
19.6.3. Strategy
19.6.4. Financial Performance
20. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
21. Market Background: Healthcare Market
21.1.1. Healthcare Market Characteristics
21.1.2. Healthcare Market Historic Growth, Value ($ Billion)
21.1.2.1. Drivers Of The Market
21.1.2.2. Restraints Of The Market
21.1.3. Healthcare Market Forecast Growth, Value ($ Billion)
21.1.3.1. Drivers Of The Market
21.1.3.2. Restraints Of The Market
21.1.4. Healthcare Trends And Strategies
21.2. Healthcare Market Regional And Country Analysis
21.2.1. Global Healthcare Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
21.2.2. Global Healthcare Market, 2013 - 2021, Historic And Forecast, By Region
21.2.3. Healthcare Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
21.2.4. Healthcare Market, 2013 - 2021, Historic And Forecast, By Country
21.2.5. Healthcare Market, Growth And Market Share Comparison, By Segment
21.2.6. Healthcare Market, Growth And Market Share Comparison, By Country And Segment
21.3. Global Healthcare Market Comparison With Macro Economic Factors
21.3.1. Healthcare Market Size, Percentage Of GDP, Global
21.3.2. Per Capita Average Healthcare Expenditure, Global
21.4. Healthcare Market Comparison With Macro Economic Factors Across Countries
21.4.1. Healthcare Market Size, Percentage Of GDP, By Country
21.4.2. Per Capita Average Healthcare Expenditure, By Country
21.5. Key Mergers And Acquisitions In The Healthcare Market
22. Appendix
22.1. NAICS Definitions Of Industry Covered In This Report
22.2. Abbreviations
22.3. Currencies
22.4. Research Inquiries
22.5. The Business Research Company
22.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report